Camphor 0.005 MG/MG / levomenthol 0.004 MG/MG / methyl salicylate 0.008 MG/MG Medicated Pa... — RxCUI 2669659
RxNorm drug concept · Semantic clinical drug
RxCUI 2669659
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2669659
Official nameCamphor 0.005 MG/MG / levomenthol 0.004 MG/MG / methyl salicylate 0.008 MG/MG Medicated Patch
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascamphor 0.5 % / levomenthol 0.4 % / methyl salicylate 0.8 % Medicated Patch
FDA products mapped2
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Methyl Salicylate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's a topical pain reliever — you apply it right to the skin where it hurts. It's used for temporary relief of minor aches and pains in your muscles and joints, things like arthri...
- What is methyl salicylate actually used for?
- No — and this is really important. You should never use methyl salicylate products with a heating pad, and avoid applying them when you're sweating from exercise or heat. Heat caus...
- Is it safe to use under a heating pad or wrap?
🕸️ Concept Web — How Camphor 0.005 MG/MG / levomenthol 0.004 MG/MG /... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Camphor 0.005 MG/MG / levomenthol 0.004 MG/MG / methyl salicylate 0.008 MG/MG Medicated Patch
RxCUI 2669659 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Camphor
1952IN -
Levomenthol
236388IN -
Methyl salicylate
29787IN -
Camphor / levomenthol / methyl salicylate
1486325MIN
-
Camphor
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Camphor / levomenthol / methyl salicylate Medicated Patch
1792991SCDF -
Camphor / levomenthol / methyl salicylate Topical Product
1486322SCDG -
Medicated Patch
1792831DF -
Topical Product
1151122DFG
-
Camphor / levomenthol / methyl salicylate Medicated Patch
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Camphor 0.005 MG/MG
329251SCDC -
Levomenthol 0.004 MG/MG
2669658SCDC -
Methyl salicylate 0.008 MG/MG
860820SCDC
-
Camphor 0.005 MG/MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Camphor 0.005 MG/MG
SCDC · 329251 -
Levomenthol 0.004 MG/MG
SCDC · 2669658 -
Methyl salicylate 0.008 MG/MG
SCDC · 860820 -
Camphor / levomenthol / methyl salicylate Medicated Patch
SCDF · 1792991 -
Camphor / levomenthol / methyl salicylate Topical Product
SCDG · 1486322
📦 FDA Products & Package NDCs
2 products · 4 package NDCs
4 package NDCs map to RxCUI 2669659 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 49873-0018-02 | 1 POUCH in 1 CARTON (49873-018-02) / 5 PATCH in 1 POUCH | Satohap | Sato Pharmaceutical Co., Ltd. | 1989-11-08 |
| 49873-0018-05 | 1 POUCH in 1 CARTON (49873-018-05) / 5 PATCH in 1 POUCH | Satohap | Sato Pharmaceutical Co., Ltd. | 1989-11-08 |
| 49873-0060-01 | 1 POUCH in 1 CARTON (49873-060-01) / 5 PATCH in 1 POUCH | Satogesic | Sato Pharmaceutical Co., Ltd. | 1990-12-03 |
| 49873-0060-02 | 1 POUCH in 1 CARTON (49873-060-02) / 5 PATCH in 1 POUCH | Satogesic | Sato Pharmaceutical Co., Ltd. | 1990-12-03 |
Observed labelers:
Sato Pharmaceutical Co., Ltd. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.